nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2022, 12, v.41;No.422 1285-1291
病理性近视患者中医体征特点调查研究
基金项目(Foundation): 国家重点研发计划项目(编号:2021YFC2702103);; 山东省中西医结合专病防治项目(编号:YXH2019ZXY001);; 山东省中医药科技项目(编号:M-2022165)
邮箱(Email):
DOI: 10.16295/j.cnki.0257-358x.2022.12.007
摘要:

目的:调查研究病理性近视患者的中医体征特点。方法:选择病理性近视患者125例作为病理性近视组,同时招募正视及低度近视大学生志愿者145例作为对照组。采用独立样本t检验分析两组中医体质、证候类型差异,并分析病理性近视组证型与体质的相关性,以及近视黄斑病变等级与不同证型、体质的相关性。结果:(1)两组中医体质及证型分布比较,差异有统计学意义(P<0.05)。病理性近视组中医证型以脾虚气弱证(58.40%)、肝肾亏虚证(28.80%)最为多见,对照组均为阴阳平衡状态;病理性近视组偏颇体质以阳虚质(26.40%)、气虚质(12.80%)为主,这两种体质患者占该组的比例均高于对照组相应体质人群占比(P<0.05)。(2)病理性近视组18~40岁患者证型以脾虚气弱证(73.33%)居多,偏颇体质以气虚质居多(24.44%);41~85岁患者证型以脾虚气弱证(50.00%)、肝肾亏虚证(40.00%)居多,偏颇体质以阳虚质(36.25%)居多。男性病理性近视患者偏颇体质以阳虚质(18.18%)、气虚质(12.73%)多见;女性病理性近视患者偏颇体质以阳虚质(32.86%)居多。(3)病理性近视组患者近视黄斑病变分级状况为:C2级84眼,C3级9眼,C4级32眼,其中以C2级(67.20%)最多见。对照组近视黄斑病变分级均为C0级。病理性近视组脾虚气弱证患者近视黄斑病变以C2级(76.71%)居多,肝肾亏虚证患者近视黄斑病变以C4级(50.00%)居多。(4)平和质、阳虚质、气虚质病理性近视患者近视黄斑病变均以C2级最为多见。结论:病理性近视患者与正视及低度近视人群的中医体质、证型分布存在差异,病理性近视患者偏颇体质以阳虚质、气虚质居多,中医证型以脾虚气弱证、肝肾亏虚证多见;不同性别、年的病理性近视患者证型、体质存在差异;证型与近视黄斑病变分级具有一定相关性。

Abstract:

Objective:To investigate the characteristics of traditional Chinese medicine(TCM) signs of patients with pathological myopia. Methods :A total of 125 patients with pathological myopia were enrolled into the study as the pathological myopia group. At the same time,145 undergraduate volunteers with emmetropia or low myopia were enrolled as the control group. The independent t test was used to analyze the differences in TCM constitution and syndrome types between the pathological myopia group and the control group. In the pathological myopia group,the correlation between syndrome types and constitution,and that among the grade of myopic macular degeneration(MMD),syndrome types and constitution were analyzed. Results:(1)The differences in distribution of TCM syndrome types and constitution between the two groups were statistically significant(P<0.05). In the pathological myopia group,the most common TCM syndrome types were spleen deficiency and qi weakness syndrome(58.40%),and liver and kidney deficiency syndrome(28.80%),while patients in the control group were in a balance state of yin and yang. The biased constitution of the pathological myopia group was dominated by yang deficiency constitution(26.40%) and qi deficiency constitution(12.80%),and the proportion of these two kinds of constitution in the pathological myopia group was higher than that in the control group(P<0.05).(2)In the patients aged 18 to 40 years,for the syndrome types,those with spleen deficiency and qi weakness syndrome(73.33%) were in a majority,and for the biased constitution,those with qi deficiency constitution(24.44%) took the largest proportion.In the patients aged 41 to 85 years,for the syndrome types,those with spleen deficiency and qi weakness syndrome(50.00%) and those with liver and kidney deficiency syndrome(40.00%) were in a majority,and for the biased constitution,those with yang deficiency constitution(36.25%) took the largest proportion. The biased constitution of male patients was dominated by yang deficiency constitution(18.18%) and qi deficiency constitution(12.73%),while that of the female patients was dominated by yang deficiency constitution(32.86%).(3)The distribution of MMD grade in the pathological myopic group were as follows :84 eyes at C2,9 eyes at C3,and 32 eyes at C4,among which the most common MMD grade was C2(67.20%). In the control group,the MMD grade of all eyes was at C0. In the pathological myopia group,the majority of MMD grade in patients with syndrome of spleen deficiency and qi weakness was C2(76.71%),and the majority of MMD grade in patients with liver and kidney deficiency syndrome was C4(50.00%).(4)In patients with gentleness constitution,in patients with yang deficiency constitution,and in patients with qi deficiency constitution,C2 was the most common MMD grade. Conclusions:There are significant differences in the distribution of TCM constitution and syndrome types between patients with pathologic myopia and people with emmetropia or low myopia. In patients with pathologic myopia,for the constitution,those with yang deficiency constitution and those with qi deficiency constitution were in a majority,and for the syndrome types,those with spleen deficiency and qi weakness syndrome and those with liver and kidney deficiency syndrome took the largest proportion. The TCM syndrome types and constitution of patients with pathologic myopia vary with gender and age. There is certain relationship between TCM syndrome types and MMD grade.

参考文献

[1] CHAN N S,TEO K,CHEUNG C M. Epidemiology and diagnosis of myopic choroidal neovascularization in Asia[J].Eye Contact Lens,2016,42(1):48-55.

[2]瞿佳,周翔天.提升近视防治研究水平的难点与要点[J].中华医学杂志,2014,94(17):1281-1283.

[3]王宁利,刘旭阳.基础眼科学前沿[M].北京:人民卫生出版社,2018:730-736.

[4]郑嘉敏,仝警安,曹妮.中医辨证论治近视的发展沿革[J].中国中医眼科杂志,2019,29(4):339-341.

[5] OHNO-MATSUI K, KAWASAKI R, JONAS J B, et al.International photographic classification and grading system for myopic maculopathy[J]. Am J Ophthalmol, 2015,159(5):877-883.

[6] VERKICHARLA P K, OHNO-MATSUI K, SAW S M.Current and predicted demographics of high myopia and an update of its associated pathological changes[J].Ophthalmic Physiol Opt,2015,35(5):465-475.

[7]国家中医药管理局.中华人民共和国中医药行业标准中医眼科病证诊断疗效标准:ZY/T001.5-94[S].南京:南京大学出版社,1994:114.

[8]中华中医药学会.中医体质分类与判定(ZYYXH/T157-2009)[J].世界中西医结合杂志2009,4(4):303-304.

[9]刘惠,刘光秀,吴佳敏,等.高度近视的中医辨证分型相关文献分析[J].中医眼耳鼻喉杂志,2018,8(1):43-45.

[10]姜小涵,向圣锦.杞菊地黄汤加减联合西药治疗白内障术后干眼症临床研究[J].新中医,2020,52(7):41-43.

[11]王炜,秦伟,王雪菁,等.视网膜内界膜剥除联合参苓白术散加味治疗特发性黄斑前膜伴黄斑水肿20例临床研究[J].四川中医,2014,32(1):99-100.

[12]胡平会,孙化萍.高度近视患者的中医体质特征初步分析[J].中国中医眼科杂志,2018,28(4):247-250.

[13]莫亚,殷庆瑞,段俊国,等.病理性近视与中医体质相关性的初步探析[J].中国中医眼科杂志,2014,24(5):317-321.

[14]杨寅,陈迪,梁远波,等. 299例北京市中小学生中医体质类型与近视关系的Logistic回归分析[J].云南中医学院学报,2013,36(6):63-66.

[15]罗晓燕,徐朝阳.中药治疗近视的理法方药初探[J].中国中医眼科杂志,2019,29(5):384-387.

基本信息:

DOI:10.16295/j.cnki.0257-358x.2022.12.007

中图分类号:R276.7

引用信息:

[1]高延娥,刘德政,蒋文君,等.病理性近视患者中医体征特点调查研究[J],2022,41(12):1285-1291.DOI:10.16295/j.cnki.0257-358x.2022.12.007.

基金信息:

国家重点研发计划项目(编号:2021YFC2702103);; 山东省中西医结合专病防治项目(编号:YXH2019ZXY001);; 山东省中医药科技项目(编号:M-2022165)

检 索 高级检索